Vlad Vitoc

Insider Reports History

Reporting-owner location: Chicago, IL
Latest reporting-owner signature: /s/ Vlad Vitoc
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Vlad Vitoc

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

MAIA Biotechnology, Inc.

Security class: Common Stock
Shares / value: 976,121
Estimated value: $1,354,563
Report date: 01 Jun 2026
Price: $1.39
Ownership: Direct

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

MAIA Biotechnology, Inc.

Security class: Stock Options
Shares / value: 800,000
Estimated value: $1,000,000
Report date: 29 May 2026
Price: $2.50
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

MAIA Biotechnology, Inc.

Security class: Common Stock
Shares / value: 210,100
Estimated value: $294,140
Report date: 01 Jun 2026
Price: $1.40
Ownership: Indirect

Insider Reports Filed by Vlad Vitoc

4 MAIA

MAIA Biotechnology, Inc.

Report period: 01 Jun 2026
Transactions: 1
Transaction value: +$100,886
Accepted by SEC: 02 Jun 2026, 09:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 29 May 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jun 2026, 08:54
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 10 Apr 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Apr 2026, 08:45
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4/A MAIA

MAIA Biotechnology, Inc.

Report period: 26 Nov 2025
Transactions: 2
Transaction value: +$79,849
Accepted by SEC: 04 Dec 2025, 07:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4/A MAIA

MAIA Biotechnology, Inc.

Report period: 25 Nov 2025
Transactions: 1
Transaction value: +$10,144
Accepted by SEC: 04 Dec 2025, 07:31
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 21 Nov 2025
Transactions: 2
Transaction value: +$11,547
Accepted by SEC: 25 Nov 2025, 16:15
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 14 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 May 2025, 16:15
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 10 Feb 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Feb 2025, 16:10
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 05 Nov 2024
Transactions: 12
Transaction value: $0
Accepted by SEC: 07 Nov 2024, 16:25
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 30 Apr 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 30 Apr 2024, 17:02
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 24 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 26 Jan 2024, 16:08
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 31 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jun 2023, 17:23
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 28 Apr 2023
Transactions: 1
Transaction value: +$10,000
Accepted by SEC: 01 May 2023, 06:30
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 03 Apr 2023
Transactions: 2
Transaction value: +$8,106
Accepted by SEC: 05 Apr 2023, 06:48
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 30 Mar 2023
Transactions: 2
Transaction value: +$5,876
Accepted by SEC: 03 Apr 2023, 09:32
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 08 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Mar 2023, 16:01
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 08 Mar 2023
Transactions: 1
Transaction value: +$6,656
Accepted by SEC: 09 Mar 2023, 05:28
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 06 Mar 2023
Transactions: 2
Transaction value: +$8,408
Accepted by SEC: 08 Mar 2023, 05:34
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 02 Mar 2023
Transactions: 2
Transaction value: +$10,918
Accepted by SEC: 06 Mar 2023, 05:19
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 28 Feb 2023
Transactions: 2
Transaction value: +$6,988
Accepted by SEC: 02 Mar 2023, 05:32
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 17 Feb 2023
Transactions: 1
Transaction value: +$310
Accepted by SEC: 22 Feb 2023, 05:24
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 15 Feb 2023
Transactions: 2
Transaction value: +$85
Accepted by SEC: 17 Feb 2023, 05:05
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 10 Feb 2023
Transactions: 1
Transaction value: +$1,454
Accepted by SEC: 14 Feb 2023, 06:00
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 04 Jan 2023
Transactions: 1
Transaction value: +$4,659
Accepted by SEC: 06 Jan 2023, 07:58
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 30 Dec 2022
Transactions: 2
Transaction value: +$9,894
Accepted by SEC: 04 Jan 2023, 06:29
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 MAIA

MAIA Biotechnology, Inc.

Report period: 16 Sep 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 20 Sep 2022, 11:18
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4/A MAIA

MAIA Biotechnology, Inc.

Report period: 01 Aug 2022
Transactions: 2
Transaction value: +$80,000
Accepted by SEC: 23 Nov 2022, 13:53
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

3 MAIA

MAIA Biotechnology, Inc.

Report period: 27 Jul 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 27 Jul 2022, 18:32
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Vlad Vitoc

Insider Reports Filed by Vlad Vitoc